Výsledky vyhledávání - "Julia Engstrom"

Understanding Factors Associated With Anaplastic Lymphoma Kinase Testing Delays in Patients With Non–Small Cell Lung Cancer in a Large Real-World Oncology Database

Autor: Yan Xiao, Denise Croix, Timothy Craig Allen, Julia Engstrom-Melnyk, Eric H. Bernicker, Stella Redpath, Baiyu Yang, Anup Abraham, R. Shah

Publikováno v: Archives of Pathology & Laboratory Medicine. 146:975-983

Context.— With multiple therapeutic options available for patients with advanced non–small cell lung cancer, the timely ordering and return of results to determine therapy are of critical importance. Objective.— To assess factors impacting anap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2d9d0bb39a7ba2631e75af66e7a1630
https://doi.org/10.5858/arpa.2021-0029-oa

Zobrazit plný text záznamu

Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data

Autor: Eric H. Bernicker, Julia Engstrom-Melynk, Baiyu Yang, Yan Xiao, Denise Croix, Stella Redpath, Jaya Madala, R. Shah, Timothy Craig Allen, Anup Abraham

Publikováno v: Oncotarget

Objective: This study assessed the prevalence of anaplastic lymphoma kinase (ALK) rearrangements in US oncology practices. Materials and Methods: Using a nationwide real-world database, we included adults with advanced non-small cell lung cancer (aNS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec3bd7a320a7033f040a098b51200c5d
http://europepmc.org/articles/PMC8590819

Zobrazit plný text záznamu

Adherence to National Comprehensive Cancer Network ALK Testing Guidelines for Patients with Advanced Non-Small Cell Lung Cancer in U.S. Community Medical Centers

Autor: Denise Croix, Timothy Craig Allen, Yan Xiao, R. Shah, Stella Redpath, Eric H. Bernicker, Julia Engstrom-Melnyk, Anup Abraham, Jaya Madala, Baiyu Yang

Publikováno v: The Oncologist

Background National Comprehensive Cancer Network (NCCN) guidelines recommend biomarker testing as the first step in the management of patients with advanced non‐small cell lung cancer (aNSCLC). We assessed anaplastic lymphoma kinase (ALK) testing r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6f4b71bd06d8cadd302351da2746732
https://doi.org/10.1002/onco.13779

Zobrazit plný text záznamu

Clinical outcomes and cost associated with HRD biomarker guided first line maintenance therapy in advanced ovarian cancer

Autor: Daniel Simmons, Jigna Bhalla, Rebecca L. Stone, Kimmie K. McLaurin, Julia Engstrom-Melnyk

Publikováno v: Gynecologic Oncology. 162:S111-S112

Objectives: Olaparib is approved as a first line (1L) maintenance (mtx) option, as monotherapy for BRCA mutated (BRCAm) ovarian cancer (OC) and in combination with bevacizumab (Bev) for homologous recombination deficient (HRD) OC. Niraparib monothera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8a3f8d56c6a5e99f66ac1357d32e4743
https://doi.org/10.1016/s0090-8258(21)00854-4

Zobrazit plný text záznamu

Biomarker testing patterns and identification of barriers to testing for homologous recombination deficiencies across four advanced-stage solid tumors in a multicommunity practice setting

Autor: Christopher M. Black, Julia Engstrom-Melnyk, Veena Shetty, Barbara L. McAneny, Scott D. Goldfarb, Kimmie K. McLaurin

Publikováno v: Journal of Clinical Oncology. 39:16-16

16 Background: Opportunities have increased for diagnostic test results to affect treatment choice in tumor types with homologous recombination deficiencies. According to NCCN Guidelines, biomarker testing has the potential to identify patients eligi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b259d3677239e734eda88cbda46152cc
https://doi.org/10.1200/jco.2020.39.28_suppl.16

Zobrazit plný text záznamu

Evaluation of Contamination Risk by the cobas e 602 Serology Module Before Viral Load Testing on the cobas 6800 System

Autor: Pedro L. Rodriguez, Julia Engstrom-Melnyk, Ed G. Marins, Stephen McCune, Leah Sakai

Publikováno v: Sexually transmitted diseases. 47(5S Suppl 1)

BACKGROUND Diagnosis of HCV, HBV, and HIV involves antibody screening followed by confirmation and/or treatment decision using nucleic acid tests. However, minimal data exist evaluating the risk of nucleic acid cross-contamination on serology devices

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbde00be66e939bad6467177151e6a57
https://pubmed.ncbi.nlm.nih.gov/31895305

Zobrazit plný text záznamu

P033 Differentiation of common genital ulcer disease pathogens using sequential or parallel molecular testing

Autor: Chris L McGowin, Stephen McCune, Julia Engstrom-Melnyk

Publikováno v: Poster Presentations.

Background The most common infectious etiologies of genital ulcers (GUs) in the USA are Herpes Simplex Virus infections (HSV1/2) and Treponema pallidum (Syphilis). GUs are a common symptom reported by men and women attending US sexual health clinics.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0c8a8e89fcb2768860f633b2a71d4f77
https://doi.org/10.1136/sextrans-2019-sti.241

Zobrazit plný text záznamu

Prevalence of ALK mutations in advanced NSCLC patients in the United States: Analysis with a real world oncology database

Autor: Eric H. Bernicker, Jaya Madala, Denise Croix, Yan Xiao, R. Shah, Julia Engstrom-Melnyk, Stella Redpath, Timothy Craig Allen, Anup Abraham, Baiyu Yang

Publikováno v: Journal of Clinical Oncology. 38:e21586-e21586

e21586 Background: ALK mutation rate is widely reported to be 3-7% of advanced non-small cell lung carcinoma (aNSCLC) patients. A cross-sectional study to assess the prevalence of ALK mutations in the real world was performed on the nationwide Flatir

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0b218bc73b7e172a69290f681588447a
https://doi.org/10.1200/jco.2020.38.15_suppl.e21586

Zobrazit plný text záznamu

Real-world testing compliance to NCCN guideline and factors of underutilization in U.S. community clinics

Autor: Yan Xiao, Eric H. Bernicker, Timothy Craig Allen, R. Shah, Stella Redpath, Denise Croix, Jaya Madala, Anup Abraham, Julia Engstrom-Melnyk, Baiyu Yang

Publikováno v: Journal of Clinical Oncology. 38:e21592-e21592

e21592 Background: Over the last 10 years, guideline recommendations for testing advanced non-small cell lung carcinomas (aNSCLC) have rapidly evolved with the identification of driver mutations and associated therapies. A retrospective study of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f47584f77b93a6738cb5b38754f02098
https://doi.org/10.1200/jco.2020.38.15_suppl.e21592

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání